Echotherapy Market Size

  • Report ID: 5953
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Echotherapy Market Size

Echotherapy Market size is expected to reach USD 3 Billion by the end of 2036, growing at a CAGR of 7% during the forecast period, i.e., 2024-2036. In the year 2023, the industry size of echotherapy was USD 1 Billion. Worldwide, the prevalence of cancer has increased, surpassing cardiovascular illnesses as the second leading cause of death. For instance, it was predicted that 18.1 million instances of cancer would occur globally in 2020. Of these cases, 9.3 million were attributed to men and 8.8 million to women. This phenomenon is caused by environmental variables such as prolonged post-reproductive lifespan, altered food habits, urbanization, and cigarette smoking. As a result, it is anticipated that the rising prevalence of cancer will lead to a global increase in oncology cancer medications. Furthermore, it is expected that in the upcoming years, the global industry would benefit from the growing public awareness of cancer.

Furthermore, expert choices for treating varicose veins have advanced with the use of echotherapy. It is the only technique that doesn't require an operating room and is completely non-invasive. Being the only method that treats from the outside of the body, it leaves no scars and enables the patient to return to their regular activities immediately. Echotherapy uses therapeutic ultrasound waves, which are the same as those used in an ultrasound examination.


Echotherapy Market
Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5953
  • Published Date: Apr 02, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

Growing incidences of neurological disorders globally, increasing technological advancements, and growing demand for echotherapy are the major factors driving the growth of the echotherapy market.

The market size of echotherapy is anticipated to attain a CAGR of 7% over the forecast period, i.e., 2024-2036.

The major players in the market are Theraclion, Royal Philips, Image-Guided Therapy, EDAP TMS, SonaCare Medical LLC, Shanghai A & S Science Technology Development Co., Ltd., ALPINION, Chongqin, Haifu Medical Technology Co., Ltd., SuperSonic Imagine, Echo Therapeutics, and others.

The prostate cancer segment is anticipated to garner the largest market size by the end of 2036 and display significant growth opportunities.

The market in the North America region is projected to hold the largest market share by the end of 2036 and provide more business opportunities in the future.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample